Skip to content

SCHEDULE 13D/AAccepted Nov 12, 4:13 PM ET

Monte Rosa Therapeutics, Inc. SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Accepted (ET)

4:13 PM

Nov 12, 2025

Filed

Nov 12, 2025

Documents

1

Size

17.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.